UBS Wealth Management: Chinese Equities Maintain Upside Potential in 2026, AI and Tech Drive Long-Term Profit Growth

Deep News2025-12-26

UBS Group AG's Chief Investment Office's wealth management unit expressed an institutional view, stating that the upward trend in the Chinese market is expected to continue into 2026, with advanced manufacturing and technological self-reliance becoming new growth engines.

As domestic investors enter the market and global capital adjusts its allocations, Chinese equities still possess room for further gains.

Currently, AI and technology are key drivers for long-term profit growth, and the technology sector—which constitutes approximately half the weighting of the MSCI China Index—is also demonstrating increasing resilience to the U.S. economic cycle and external shocks.

China's pace of AI monetization leads other markets, with the Hang Seng Tech Index projected to achieve 37% earnings per share growth in 2026.

Against a backdrop of low interest rates and limited alternative investment options, approximately 7 trillion yuan in excess household savings is expected to flow into the stock market.

The outlook for the Chinese market remains positive, with a focus on cloud computing, e-commerce, AI, digital infrastructure, and selected telecommunications, financial, and utility companies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment